Table 1. Cytotoxicity against Cultured Human Prostate Cancer Cells^a.

	LNCaP Cells		PC-3 Cells
Drug	IC50(μM)	IC90(μM)	IC50(μM)	IC90(μM)
Enigmol	11.7 ± 1.10	19.6 ± 1.10	12.1 ± 1.02	14.0 ± 1.00
CF3-Enigmol	11.3 ± 1.10	19.2 ± 1.30	21.4 ± 1.17	24.4 ± 1.20
CF2-Enigmol	13.4 ± 1.07	16.7 ± 1.20	11.7 ± 1.05	15.3 ± 1.10

^aLNCaP or PC-3 cells were incubated with compound for 24 h (n = 3–4), and viability was assessed using WST-1. Data represent the mean ± SEM.